Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING

Ping Lai1, Lei Liu2, Nicolò Bancaro2

  • 1Institute of Oncology Research (IOR), Bellinzona 6500, Switzerland; Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne 1011, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano 6962, Switzerland.

Immunity
|April 9, 2025
PubMed

Insights

Senescent cells release mitochondrial DNA (mtDNA) packaged in vesicles, which enhances immunosuppressive myeloid cells in tumors. Inhibiting mtDNA release via VDAC channels improved chemotherapy efficacy in prostate cancer models.

Area of Science:

  • Immunology
  • Cellular Biology
  • Cancer Research

Background:

  • Cellular senescence is linked to mitochondrial dysfunction.
  • The role of extracellular mitochondrial DNA (mtDNA) in innate immunity and tumor progression is not fully understood.

Purpose of the Study:

  • To investigate the release of mtDNA from senescent cells.
  • To determine the impact of extracellular mtDNA on the tumor microenvironment and innate immunity.
  • To explore the therapeutic potential of targeting mtDNA release.

Main Methods:

  • Primary and therapy-induced senescent cells were analyzed for mtDNA release.
  • Extracellular vesicles containing mtDNA were characterized.
  • The transfer of mtDNA to polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) was studied.
  • cGAS-STING-NF-κB and PERK signaling pathways were investigated.
  • Voltage-dependent anion channels (VDACs) were targeted pharmacologically in prostate cancer mouse models.

Main Results:

  • Senescent cells actively release mtDNA into the extracellular environment, packaged within extracellular vesicles.
  • Extracellular mtDNA is transferred to PMN-MDSCs, enhancing their immunosuppressive activity via cGAS-STING-NF-κB and PERK signaling.
  • Pharmacological inhibition of VDAC reduced extracellular mtDNA, reversed PMN-MDSC immunosuppression, and improved chemotherapy efficacy in preclinical models.

Conclusions:

  • Extracellular mtDNA released by senescent cells promotes tumor progression by enhancing PMN-MDSC immunosuppression.
  • Targeting VDAC-mediated mtDNA release offers a potential strategy to reprogram the tumor microenvironment.
  • Inhibiting mtDNA release may improve therapeutic outcomes for cancer patients undergoing chemotherapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
8.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K